Wealthstreet Investment Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
FCM
Wealthstreet Investment Advisors's AGN Position: Q1 2020 in Review
Wealthstreet Investment Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,495 shares — an estimated $286K sold.
Wealthstreet Investment Advisors first reported a position in AGN in Q4 2017 and held it in 9 quarters. The position peaked at $1.37M in Q3 2018. 875 funds tracked by Wall St. Rank hold AGN as of Q1 2020.
- Wealthstreet Investment Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
- Wealthstreet Investment Advisors sold 1,495 Allergan plc shares in Q1 2020, an estimated $286K.
- Wealthstreet Investment Advisors first reported a position in Allergan plc in Q4 2017 and held it in 9 quarters.
- Wealthstreet Investment Advisors's Allergan plc position peaked at $1.37M in Q3 2018.
- 875 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.
Based on Wealthstreet Investment Advisors's 13F filing for Q1 2020, filed 1 May 2020.